Community Community Rallies Around Children With Rare Disease BY SAMUEL BR ASLOW
Daryoosh and Gladi with their children, Yonatan and Revital. Photo by Samuel Braslow. The first sign of trouble came when Yonatan Golian, an otherwise healthy 12-year-old boy, fell to his living room floor in an epileptic fit. Two years later, after Yonatan had begun treatment for epilepsy, the unthinkable happened; his younger sister, Revital had her first seizure. Faced with the improbability that two siblings
PAGE 6
both had epilepsy, doctors administered genetic tests and identified the culprit: Lafora disease, a rare and terminal genetic illness. Daryoosh Golian Moghaddam and his wife Gladi Gidanian had never heard of Lafora disease until their children’s diagnosis. The genetic disease occurs at a rate of one in a
million, mostly in the Mediterranean and the Middle East. Lafora presents as a combination of Alzeihmer’s, Parkinson’s, and epilepsy beginning in early adolescence. Affected individuals typically live for 10 years after showing symptoms. Gladi and Daryoosh, who are Jewish, brought their family to the United States from Iran 10 years ago in pursuit of “the American Dream.” Gladi remembers her childhood in Iran fondly, but like Daryoosh, she worried about her children growing up as second-class citizens in Muslim-majority Iran. “We had to wear uniforms and scarves, we had to go to school on Shabbat, and as a Jew, you can’t get certain degrees,” she said. While the family could have afforded to buy a house in Glendale or possibly Encino, the four of them landed in a two-bedroom apartment in Beverly Hills for one reason: “Good schools,” Daryoosh said. Before the daily regimen of pills, before the seizures, before Lafora, “everything was good,” Gladi said. “The kids were blooming,” Gladi recalled. “In just a span of six months, they were talking [English] like their mother language.” Now, Yonatan can barely walk on his own and speaks only a handful of words each day.
Revital went without a seizure for nearly two years and seemed relatively unaffected until recently. But within just the last 30 days, she went from speaking full sentences with ease to stumbling over her words, growing frustrated when she cannot find words that she knew the day before. The process is unbearable, and yet, as Gladi told the Courier, she and Daryoosh have had no choice but to bear it. Lacking both money and time, the Golians have pinned their hopes to an expensive experimental treatment that may give the children a chance at survival. And with a massive outpouring of support from the community, they may be able to afford it in time. Multiple possible treatments for Lafora are in various stages of development, says Dr. Matthew Gentry, a professor at the University of Kentucky. Gentry, who is in contact with the Golians, is at the forefront of an international search for a treatment as Director of the Lafora Epilepsy Cure Initiative. Gentry could not comment specifically on the Golians, citing confidentiality, but he spoke broadly about the recent advancements made in the field. (Community Rallies continues on page 13)
NOVEMBER 5, 2021
